Botanix Pharmaceuticals (BOT) Short Interest
Botanix Pharmaceuticals (ASX:BOT) had 0.62% of shares reported as short positions as of 24 Aug 2026, representing 17,027,598 shares. Botanix Pharmaceuticals operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Botanix Pharmaceuticals
Botanix Pharmaceuticals is an Australian clinical dermatology company focused on developing and commercializing innovative treatments for common skin diseases. Their lead product candidate is Sofdra, a potential treatment for primary axillary hyperhidrosis, and they are also developing other products for acne and atopic dermatitis.
Short position
Botanix Pharmaceuticals (ASX:BOT) has 0.62% of its shares on issue reported as short positions as of 24 Aug 2026, or about 17,027,598 shares. Over the past 30 days that figure has risen 0.13 percentage points, and over 90 days it has been broadly flat. Its highest recorded short interest was 4.26% in July 2025. BOT is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4BOT intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Botanix Pharmaceuticals
Latest BOT news
All news- Botanix Pharmaceuticals (ASX:BOT) Sofdra Expansion Gains Momentum as Patent Progress and Commercial Growth Advance - Kalkine
googlenews
- Appendix 4G and Corporate Governance Statement
asx
- Appendix 4E & Annual Report for the Year Ended 30 June 2026
asx
- Notification regarding unquoted securities - BOT
asx
- Application for quotation of securities - BOT
asx
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss BOT
Start a research thread or post the first pulse update